NCT05833607

Brief Summary

The sudy objective is to evaluate the cerebral haemodynamic status in different ranges of systemic arterial pressure in patients with septic shock by noninvasive tools, transcranial doppler and intracranial compliance by mechanical sensor (B4C). Patients participating in the study will be submitted to different levels of arterial pressure, titrated with vasopressor and them their cerebral hemodynamic variables will be evaluated,

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 7, 2022

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 29, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 27, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2024

Completed
Last Updated

April 27, 2023

Status Verified

April 1, 2023

Enrollment Period

1.5 years

First QC Date

March 29, 2023

Last Update Submit

April 17, 2023

Conditions

Keywords

Septic ShockCerebral autoregulationCerebral hemodynamics

Outcome Measures

Primary Outcomes (1)

  • The primary objective is to evaluate the effects of cerebral haemodynamic in patients with septic shock in different targets of MAP, through ARI (by Transcranial Doppler), and intracranial compliance by mechanical sensor (B4C)

    This outcome will be analyzed by transcranial Doppler (ARI, PI) and B4C (intracranial compliance) index). Data will be obtained at the time of collection (mean arterial pressure targets) and subsequently analyzed

    Data will be obtained at the time of collection (mean arterial pressure targets) and subsequently analyzed

Secondary Outcomes (4)

  • Assess factors that influence cerebral autoregulation (by ARI) and intracranial compliance (B4C)

    Data will be obtained at the time of collection (mean arterial pressure targets) and subsequently analyzed

  • Evaluate the correlation between CA by TDC and B4C index.

    Data will be obtained at the time of collection (mean arterial pressure targets) and subsequently analyzed

  • Correlate mechanical ventilation time with perfusion pressure value

    Mechanical ventilation time up to 28 days

  • Explore the correlation between incidence of brain dysfunction

    Until 28º day

Study Arms (1)

ALL PATIENTS

All patients are monitored with the transcranial Doppler helmet and the 2Hz probe in one of the middle cerebral hemispheres and the Brain 4 care on the other side. Necessary monitoring: arterial line, electrocardiographic monitor, pulse oximetry, temperature. ETCO2 monitoring whenever possible. Step 1: Test arterial line circuit, ensure proper temperature, arterial blood gases Step 2: Record data with the patient's baseline pressure (data from the monitor, transcranial doppler and brain4care), for 5 min Step 3: Vasopressor titrant for 3 MAP targets (65, 75 and 85 mmHg) , record data with the patient's baseline pressure (data from the monitor, transcranial doppler and brain4care), each target record for 3 minutes Step 4: Arterial blood gases, gradually restore PAM to baseline value

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with septic shock with less than 48 hours of ICU stay

You may qualify if:

  • \< 48 hours in the intensive care unit
  • Septic shock (sepsis 3.0)

You may not qualify if:

  • No window for DTC
  • Hepatic or uremic encephalopathy
  • Pregnancy
  • Acute or prior structural neurological insult
  • Exogenous intoxication
  • Dementia
  • Chronic Obstructive Pulmonary Disease
  • Instability for acute arrhythmia
  • Extracorporeal support by modifying the pulse wave form (intra aortic balloon pump and Extracorporeal membrane oxygenation
  • Extreme severity, with imminent risk of death

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

São Rafael Hospital

Salvador, Estado de Bahia, 41253-190, Brazil

RECRUITING

Related Publications (1)

  • Cury P, Passos RDH, Alves F, Brasil S, Frigieri G, Taccone FS, Panerai RB, Caldas J. Impact of different blood pressure targets on cerebral hemodynamics in septic shock: A prospective pilot study protocol-SEPSIS-BRAIN. PLoS One. 2024 Oct 14;19(10):e0304412. doi: 10.1371/journal.pone.0304412. eCollection 2024.

Related Links

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Juliana Caldas, Phd

    D'Or Institute for Research and Education (IDOR), Hospital São Rafael

    PRINCIPAL INVESTIGATOR
  • Pedro Cury

    D'Or Institute for Research and Education (IDOR), Hospital São Rafael

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2023

First Posted

April 27, 2023

Study Start

July 7, 2022

Primary Completion

December 30, 2023

Study Completion

July 7, 2024

Last Updated

April 27, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

We don't have that plan, but if the data is useful for larger research, no problem.

Locations